Rivian is building its own AI assistant in-house, a project separate from its $5.8 billion tech joint venture with Volkswagen. The company is targeting a release by the end of the year and will detail its plans at a live-streamed event on December 11.
As companies fear deploying AI agents due to security risks, identity management vendors are spotting a major opportunity. Okta’s new Auth0 for AI Agents tool aims to provide the guardrails and logging that CISOs desperately need.
A new IDC report is making bold predictions for the foldable phone market in 2026, forecasting 30% year-over-year growth. The biggest driver? Apple’s long-rumored “iPhone Fold,” expected to launch at the end of next year.
President Trump announced plans for an executive order this week to set federal AI rules and override state-level regulations. The move aims to prevent companies from needing “50 Approvals” but could spark major legal battles over states’ rights and AI governance.
India is proposing a mandatory blanket license for AI companies, requiring them to pay royalties to creators for using copyrighted training data. The move targets giants like OpenAI and Google in one of their fastest-growing markets and could reshape global AI regulation.
Fortune’s annual healthcare predictions from top investors are in, and they’re bracing for a wild 2026. They foresee AI doctors struggling with business, a potential blockbuster sale of Epic to Microsoft, and even higher drug prices. After a rough scoring year in 2025, they’re throwing in some bold
Samsung’s follow-up to its 2024 Galaxy Ring is in limbo. The company is locked in a two-way patent war with rival Oura, and a new report suggests the Galaxy Ring 2 won’t debut at next year’s key February event.
President Trump says he’s watching the high-stakes fight for Warner Bros. Discovery between Netflix and Paramount. His regulatory approval could be the deciding factor in the $72 billion deal.
Forget robotic doctors. The real AI healthcare revolution is happening right now in apps and wearables. Roughly one in three Americans already uses some form of AI to manage their health, tackling everything from diabetes to depression. But the evidence on effectiveness is a real mixed bag.
Skild AI is reportedly in talks for a funding round that could involve SoftBank and Nvidia. The deal could push the robotics company’s valuation to around $14 billion, nearly triple its $4.7 billion valuation from earlier this year.
